#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA710914	F	Anti MDR activity was expressed as MDR ratio or MDR fold reversal in doxorubicin resistant human breast carcinoma tumor cell line MCF-7/DOX	Homo sapiens	39	ALA1131228	cell-based format	Scientific Literature
2.	ALA854304	F	Cytotoxic potency in doxorubicin resistant MCF7 cell line after 72 hr exposure by SRB test	Homo sapiens	5	ALA1141208	cell-based format	Scientific Literature
3.	ALA862405	F	Antiproliferative activity against doxorubicin-resistant human MCF7-dx cells	Homo sapiens	6	ALA1147810	cell-based format	Scientific Literature
4.	ALA4343381	F	Antiproliferative activity against human MCF7/Dox cells by SRB assay	Homo sapiens	3	ALA4342418	cell-based format	Scientific Literature
5.	ALA4343388	F	Potency index, ratio of etoposide IC50 to test compound IC50 for antiproliferative activity against human MCF7/Dox cells by SRB assay	Homo sapiens	1	ALA4342418	cell-based format	Scientific Literature
6.	ALA4361912	A	Cytotoxicity against human MCF7/Dox cells assessed as reduction in cell viability after 48 hrs by MTT assay	Homo sapiens	33	ALA4359857	cell-based format	Scientific Literature
7.	ALA4361913	A	Cytotoxicity against human MCF7/Dox cells assessed as cell survival at 12.5 uM after 48 hrs by MTT assay relative to control	Homo sapiens	33	ALA4359857	cell-based format	Scientific Literature
8.	ALA4361921	A	Cytotoxicity against human MCF7/Dox cells assessed as growth inhibition after 48 hrs by MTT assay	Homo sapiens	1	ALA4359857	cell-based format	Scientific Literature
9.	ALA4361925	F	Down regulation of p-gp protein expression in human MCF7/Dox cells at 12.5 uM in presence of doxorubicin by Western blotting analysis	Homo sapiens	1	ALA4359857	cell-based format	Scientific Literature
10.	ALA4361926	F	Down regulation of p-gp mRNA expression in human MCF7/Dox cells at 12.5 uM in presence of doxorubicin after 48 hrs by RT-PCR analysis	Homo sapiens	1	ALA4359857	cell-based format	Scientific Literature
11.	ALA4361928	F	Antitumour activity against human MCF7/Dox cells xenografted in Balb/c mouse assessed as tumour growth inhibition at 2 mg/kg measured after 30 days	Homo sapiens	1	ALA4359857	organism-based format	Scientific Literature
12.	ALA4361929	F	Antitumour activity against human MCF7/Dox cells xenografted in Balb/c mouse assessed as tumour growth inhibition at 5 to 15 mg/kg in presence of doxorubicin and measured after 30 days	Homo sapiens	1	ALA4359857	organism-based format	Scientific Literature
13.	ALA4361932	F	Antimigratory activity against human MCF7/Dox cells after after 24 hrs by wound healing assay	Homo sapiens	1	ALA4359857	cell-based format	Scientific Literature
14.	ALA4361934	F	Antimigratory activity against human MCF7/Dox cells after 36 hrs by by crystal violet staining based transwell migration assay	Homo sapiens	1	ALA4359857	cell-based format	Scientific Literature
15.	ALA4361935	F	Antitumour activity against human MCF7/Dox cells xenografted in Balb/c mouse assessed as reduction in tumour volume at 5 to 15 mg/kg and measured after 30 days	Homo sapiens	1	ALA4359857	organism-based format	Scientific Literature
16.	ALA4361936	F	Antitumour activity against human MCF7/Dox cells xenografted in Balb/c mouse assessed as reduction in tumour weight at 5 to 15 mg/kg and measured after 30 days	Homo sapiens	1	ALA4359857	organism-based format	Scientific Literature
17.	ALA4480832	F	Cytotoxicity against human MCF7/Dox cells after 72 hrs by MTT assay	Homo sapiens	4	ALA4480387	cell-based format	Scientific Literature
18.	ALA4613556	F	Anticancer activity against human MCF7/Dox cells after 48 hrs by SRB assay	Homo sapiens	2	ALA4613209	cell-based format	Scientific Literature
19.	ALA4613574	F	Potency index, ratio of IC50 for etoposide to IC50 for test compound for anticancer activity against human MCF7/Dox cells after 48 hrs by SRB assay	Homo sapiens	1	ALA4613209	cell-based format	Scientific Literature